论文部分内容阅读
目的:探讨米索前列醇联合缩宫素预防剖宫产出血的临床效果。方法:将我院自2010年1月～2012年4月收治的剖宫产患者60例,随机分为治疗组(30例)和对照组(30例),治疗组在胎儿娩出后采用缩宫素20μg宫体注射,并舌下含化米索前列醇400μg;对照组在胎儿娩出后仅给予缩宫素20μg宫体注射,比较2组患者术后的出血量。结果:术后治疗组的出血量明显少于对照组,2组比较,差异具有统计学意义(P<0.05)。结论:米索前列醇联合缩宫素预防剖宫产出血的临床效果显著,具有很强的子宫收缩能力,能显著减少术后出血,用药方便,安全,是防治剖宫产出血的有效药物,值得临床推广应用。
Objective: To investigate the clinical effect of misoprostol combined with oxytocin in preventing bleeding after cesarean section. Methods: 60 cases of cesarean section in our hospital from January 2010 to April 2012 were randomly divided into treatment group (30 cases) and control group (30 cases). After treatment, 20μg uterine body injection, and sublingual misoprostol 400μg; control group was given only after injection of oxytocin 20μg uterine body injection, the amount of bleeding in two groups were compared. Results: The bleeding volume of the postoperative treatment group was significantly less than that of the control group, the difference was statistically significant (P <0.05). Conclusion: The clinical effect of misoprostol combined with oxytocin in preventing cesarean section bleeding is significant. It has a strong uterine contractility, can significantly reduce postoperative bleeding, convenient and safe medication, is an effective drug for prevention and treatment of cesarean section bleeding, Worthy of clinical application.